A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

Point-of-care testing identifies ARDS inflammatory subphenotypes in real time, offering insights into patient prognosis and mortality risks.

Every second counts in the Intensive Care Unit (ICU), with changes in patient status potentially occurring quickly and with no prior warning. Around-the-clock blood testing capabilities are essential ...

MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. – Blood is supposed to clot; that’s why a simple cut doesn’t lead to bleeding to death. But, as with so many things related to the human ...

Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...

Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...